Table 3.
Tumour recurrence and survival analyses
| LGS(n = 22) | OGS(n = 25) | P value | |
| Overall 5 yr mortality rate | 12 (54.5%) | 14 (56%) | 1 |
| Cancer-related 5 yr mortality rate | 11 (50%) | 13 (52%) | 1 |
| FU (5 yr) accomplishment | 20 (91%) | 23 (92%) | 1 |
| Type of recurrence | 0.9 | ||
| Port-site M | 0 (0%) | ||
| Locoregional/carcinosis | 2 (18%) | 4 (31%) | |
| Hepatic M | 6 (55%) | 6 (46%) | |
| Distant M | 3 (27%) | 3 (23%) | |
| Median survival, mo (range) | 39 (12-60) | 38 (11-60) | 0.7 |
| Disease free interval, mo (range) | 28 (12-60) | 26 (10-60) | 0.6 |
LGS: Laparoscopic gastric surgery; OGS: Open gastric surgery; FU: Follow up.